Technology area: Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Raysearch Laboratories AB (Publ) is currently navigating 2 pending office actions in the Semiconductors, Circuits & Optics technology area. These actions are located in 2 distinct art units, which suggests that the company's developments span different chemical or optical classifications. The involvement of 2 distinct examiners means that the prosecution is not centralized under a single person. This distribution across 2 distinct art units highlights the varied nature of the company's current patent applications.
MCCORMACK, JASON L is the busiest examiner for this portfolio, currently handling 1 pending office action. The 2 pending office actions are divided between the 2 distinct examiners, resulting in a balanced distribution of the current workload. Since the pending office actions are being reviewed in 2 distinct art units, practitioners should be prepared for different technical requirements and examination standards. The 1 pending office action assigned to MCCORMACK, JASON L requires a strategy tailored to that examiner's specific approach in the Semiconductors, Circuits & Optics sector. Coordinating between the 2 distinct examiners is necessary to maintain a unified prosecution strategy. This structure ensures that each of the 2 pending office actions receives specialized attention within its respective art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMACK, JASON L | 1 | 84.7% | +8.1% |
| LE, TUNG X | 1 | 87.0% | +3.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18682384 | Methods and devices for simulating charged-particle transport in an external magnetic field, with applications to radiotherapy planning | LE, TUNG X | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18860133 | Radiotherapy treatment planning and means for radiotherapy treatment delivery | MCCORMACK, JASON L | — |
| Art Unit | Apps |
|---|---|
| 2881 | 1 |
| 2845 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18860133 | Radiotherapy treatment planning and means for radiotherapy treatment delivery | MCCORMACK, JASON L | 2881 | §102§103 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18682384 | Methods and devices for simulating charged-particle transport in an external magnetic field, with applications to radiotherapy planning | LE, TUNG X | 2845 | §112 | Non-Final OA | — | Pending | Feb 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRaysearch Laboratories AB (Publ) has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Jason L Mccormack has the most, with 1 of Raysearch Laboratories AB (Publ)'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
